Aline Miller

New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions

Retrieved on: 
Thursday, August 11, 2022
Knowledge, FDA, Death, Biomarker, The Lancet, NYSE, United States Department of Defense, United States Army Medical Research and Development Command, Ubiquitin, Neuron, Brain, CT, Transformative research, Disability, Research, Life, Blood, Probability, Plasma, Ubiquitin carboxy-terminal hydrolase L1, U.S. Department of Defense Strategy for Operating in Cyberspace, Patient, Prognosis, Twitter, Glial fibrillary acidic protein, National Health and Nutrition Examination Survey, GFAP, Mark (given name), United States Army Medical Materiel Agency, EDTA, University, Aline Miller, Emergency medicine, Head, Protein, United States Army Medical Research Institute of Infectious Diseases, LinkedIn, Neurology, Traumatic brain injury, Medical device, Medical imaging, TBI

Researchers measured levels of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin carboxy-terminal Hydrolase L1 (UCH-L1) present in blood plasma within 24 hours of injury.

Key Points: 
  • Researchers measured levels of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin carboxy-terminal Hydrolase L1 (UCH-L1) present in blood plasma within 24 hours of injury.
  • The researchers found that high values of the biomarkers, GFAP and UCH-L1, correlate with death and severe injury.
  • Test results are available approximately 15 minutes after a plasma sample is inserted in the test i-STAT cartridge.
  • More information is available at www.globalpointofcare.abbott/en/product-details/apoc/istat-tbi-plasma.html
    The i-STAT Alinity is an easy-to-use, portable blood analyzer that delivers real-time, lab-quality diagnostic test results.

New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions

Retrieved on: 
Thursday, August 11, 2022
Knowledge, FDA, Death, Biomarker, The Lancet, NYSE, United States Department of Defense, United States Army Medical Research and Development Command, Ubiquitin, Neuron, Brain, CT, Transformative research, Disability, Research, Life, Blood, Probability, Plasma, Ubiquitin carboxy-terminal hydrolase L1, U.S. Department of Defense Strategy for Operating in Cyberspace, Patient, Prognosis, Twitter, Glial fibrillary acidic protein, National Health and Nutrition Examination Survey, GFAP, Mark (given name), United States Army Medical Materiel Agency, EDTA, University, Aline Miller, Emergency medicine, Head, Protein, United States Army Medical Research Institute of Infectious Diseases, LinkedIn, Neurology, Traumatic brain injury, Medical device, Medical imaging, TBI

Researchers measured levels of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin carboxy-terminal Hydrolase L1 (UCH-L1) present in blood plasma within 24 hours of injury.

Key Points: 
  • Researchers measured levels of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin carboxy-terminal Hydrolase L1 (UCH-L1) present in blood plasma within 24 hours of injury.
  • The researchers found that high values of the biomarkers, GFAP and UCH-L1, correlate with death and severe injury.
  • Test results are available approximately 15 minutes after a plasma sample is inserted in the test i-STAT cartridge.
  • More information is available at www.globalpointofcare.abbott/en/product-details/apoc/istat-tbi-plasma.html
    The i-STAT Alinity is an easy-to-use, portable blood analyzer that delivers real-time, lab-quality diagnostic test results.